TreeWAS – Variant ID: rs293748

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D86.9 Sarcoidosis, unspecified	0.048	0.952	0.000
D86 Sarcoidosis	0.044	0.956	0.000
D86.0 Sarcoidosis of lung	0.040	0.960	0.000
D86.1 Sarcoidosis of lymph nodes	0.038	0.962	0.000
E87.1 Hypo-osmolality and hyponatraemia	0.035	0.965	0.000
D86.3 Sarcoidosis of skin	0.032	0.968	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.032	0.968	0.000
D80-D89 Certain disorders involving the immune mechanism	0.031	0.969	0.000
D80 Immunodeficiency with predominantly antibody defects	0.027	0.973	0.000
D86.8 Sarcoidosis of other and combined sites	0.025	0.975	0.000
D84 Other immunodeficiencies	0.025	0.975	0.000
D83 Common variable immunodeficiency	0.024	0.976	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.024	0.976	0.000
D82 Immunodeficiency associated with other major defects	0.022	0.978	0.000
D81 Combined immunodeficiencies	0.022	0.978	0.000
D80.1 Nonfamilial hypogammaglobulinaemia	0.021	0.979	0.000
D84.8 Other specified immunodeficiencies	0.020	0.980	0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.020	0.980	0.000
E87 Other disorders of fluid, electrolyte and acid-base balance	0.020	0.980	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.019	0.980	0.000
D80.8 Other immunodeficiencies with predominantly antibody defects	0.019	0.980	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.019	0.980	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.019	0.980	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.019	0.980	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.019	0.980	0.000
D80.0 Hereditary hypogammaglobulinaemia	0.019	0.980	0.000
D83.9 Common variable immunodeficiency, unspecified	0.019	0.981	0.000
E87.0 Hyperosmolality and hypernatraemia	0.019	0.981	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.019	0.981	0.000
D84.9 Immunodeficiency, unspecified	0.018	0.982	0.000
D84.1 Defects in the complement system	0.018	0.982	0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.018	0.982	0.000
D83.8 Other common variable immunodeficiencies	0.017	0.983	0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.017	0.983	0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.017	0.983	0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.017	0.983	0.000
E87.5 Hyperkalaemia	0.017	0.983	0.000
D81.9 Combined immunodeficiency, unspecified	0.016	0.984	0.000
D81.8 Other combined immunodeficiencies	0.016	0.984	0.000
D81.7 Major histocompatibility complex class II deficiency	0.016	0.984	0.000
D81.6 Major histocompatibility complex class I deficiency	0.016	0.984	0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.016	0.984	0.000
D81.4 Nezelof's syndrome	0.016	0.984	0.000
D81.3 Adenosine deaminase [ADA] deficiency	0.016	0.984	0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.016	0.984	0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.016	0.984	0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.016	0.984	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.016	0.984	0.000
D82.8 Immunodeficiency associated with other specified major defects	0.016	0.984	0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.016	0.984	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.016	0.984	0.000
D82.2 Immunodeficiency with short-limbed stature	0.016	0.984	0.000
D82.1 Di George's syndrome	0.016	0.984	0.000
D82.0 Wiskott-Aldrich syndrome	0.016	0.984	0.000
E87.7 Fluid overload	0.015	0.985	0.000
E87.4 Mixed disorder of acid-base balance	0.014	0.986	0.000
E87.3 Alkalosis	0.014	0.986	0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.013	0.986	0.000
D89.3 Immune reconstitution syndrome	0.013	0.986	0.000
D89.1 Cryoglobulinaemia	0.013	0.986	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.013	0.986	0.000
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.013	0.987	0.000
K70 Alcoholic liver disease	0.013	0.987	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.012	0.988	0.000
K70.9 Alcoholic liver disease, unspecified	0.012	0.988	0.000
K72.9 Hepatic failure, unspecified	0.012	0.988	0.000
E87.6 Hypokalaemia	0.012	0.988	0.000
K70-K77 Diseases of liver	0.012	0.988	0.000
K72 Hepatic failure, not elsewhere classified	0.012	0.988	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.011	0.988	0.000
K75.0 Abscess of liver	0.011	0.989	0.000
K75 Other inflammatory liver diseases	0.011	0.989	0.000
C32.9 Larynx, unspecified	0.011	0.989	0.000
K70.4 Alcoholic hepatic failure	0.011	0.989	0.000
C32 Malignant neoplasm of larynx	0.010	0.990	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.010	0.990	0.000
K74.6 Other and unspecified cirrhosis of liver	0.010	0.990	0.000
C32.0 Glottis	0.010	0.990	0.000
C32.1 Supraglottis	0.010	0.990	0.000
K74 Fibrosis and cirrhosis of liver	0.010	0.990	0.000
K70.0 Alcoholic fatty liver	0.010	0.990	0.000
K75.8 Other specified inflammatory liver diseases	0.010	0.990	0.000
K70.3 Alcoholic cirrhosis of liver	0.009	0.991	0.000
K76 Other diseases of liver	0.009	0.991	0.000
K72.0 Acute and subacute hepatic failure	0.009	0.991	0.000
K70.1 Alcoholic hepatitis	0.009	0.991	0.000
K72.1 Chronic hepatic failure	0.009	0.991	0.000
K77 Liver disorders in diseases classified elsewhere	0.009	0.991	0.000
K71 Toxic liver disease	0.009	0.991	0.000
J33.8 Other polyp of sinus	0.009	0.991	0.000
Z74.0 Reduced mobility	0.000	0.992	0.008
K76.6 Portal hypertension	0.008	0.992	0.000
K75.2 Nonspecific reactive hepatitis	0.008	0.992	0.000
K75.1 Phlebitis of portal vein	0.008	0.992	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.008	0.992	0.000
C32.8 Overlapping lesion of larynx	0.008	0.992	0.000
C32.3 Laryngeal cartilage	0.008	0.992	0.000
C32.2 Subglottis	0.008	0.992	0.000
K76.0 Fatty (change of) liver, not elsewhere classified	0.008	0.992	0.000
K76.8 Other specified diseases of liver	0.008	0.992	0.000
K73 Chronic hepatitis, not elsewhere classified	0.007	0.993	0.000
K74.4 Secondary biliary cirrhosis	0.007	0.993	0.000
K74.2 Hepatic fibrosis with hepatic sclerosis	0.007	0.993	0.000
K74.1 Hepatic sclerosis	0.007	0.993	0.000
K76.5 Hepatic veno-occlusive disease	0.007	0.993	0.000
K76.4 Peliosis hepatis	0.007	0.993	0.000
K76.3 Infarction of liver	0.007	0.993	0.000
K76.2 Central haemorrhagic necrosis of liver	0.007	0.993	0.000
K76.1 Chronic passive congestion of liver	0.007	0.993	0.000
K75.4 Autoimmune hepatitis	0.007	0.993	0.000
I08.0 Disorders of both mitral and aortic valves	0.007	0.993	0.000
D23.3 Skin of other and unspecified parts of face	0.007	0.993	0.000
G51.0 Bell's palsy	0.000	0.993	0.007
K71.9 Toxic liver disease, unspecified	0.006	0.993	0.000
K71.8 Toxic liver disease with other disorders of liver	0.006	0.993	0.000
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.006	0.993	0.000
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.006	0.993	0.000
K71.5 Toxic liver disease with chronic active hepatitis	0.006	0.993	0.000
K71.4 Toxic liver disease with chronic lobular hepatitis	0.006	0.993	0.000
K71.3 Toxic liver disease with chronic persistent hepatitis	0.006	0.993	0.000
K71.2 Toxic liver disease with acute hepatitis	0.006	0.993	0.000
K71.1 Toxic liver disease with hepatic necrosis	0.006	0.993	0.000
K71.0 Toxic liver disease with cholestasis	0.006	0.993	0.000
K77.8 Liver disorders in other diseases classified elsewhere	0.006	0.993	0.000
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.006	0.993	0.000
K74.0 Hepatic fibrosis	0.006	0.993	0.000
K76.7 Hepatorenal syndrome	0.006	0.994	0.000
U89.8 Agent resistant to other single specified antibiotic	0.006	0.994	0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.006	0.994	0.000
D69.6 Thrombocytopenia, unspecified	0.006	0.994	0.000
E21.0 Primary hyperparathyroidism	0.006	0.994	0.000
K74.5 Biliary cirrhosis, unspecified	0.006	0.994	0.000
E87.2 Acidosis	0.006	0.994	0.000
I07.1 Tricuspid insufficiency	0.006	0.994	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.005	0.994	0.000
K73.8 Other chronic hepatitis, not elsewhere classified	0.005	0.994	0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.005	0.994	0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.005	0.994	0.000
K75.9 Inflammatory liver disease, unspecified	0.005	0.994	0.000
K74.3 Primary biliary cirrhosis	0.005	0.995	0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.005	0.995	0.000
F10.1 Harmful use	0.005	0.995	0.000
U89 Agent resistant to other and unspecified antibiotics	0.005	0.995	0.000
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.005	0.995	0.000
I08 Multiple valve diseases	0.005	0.995	0.000
I07 Rheumatic tricuspid valve diseases	0.005	0.995	0.000
D69 Purpura and other haemorrhagic conditions	0.005	0.995	0.000
D55-D59 Haemolytic anaemias	0.005	0.995	0.000
U88 Agent resistant to multiple antibiotics	0.005	0.995	0.000
D65 Disseminated intravascular coagulation [defibrination syndrome]	0.005	0.995	0.000
D56 Thalassaemia	0.004	0.996	0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.004	0.996	0.000
H25.0 Senile incipient cataract	0.004	0.996	0.000
D72.8 Other specified disorders of white blood cells	0.004	0.996	0.000
I05-I09 Chronic rheumatic heart diseases	0.004	0.996	0.000
K61.3 Ischiorectal abscess	0.000	0.996	0.004
D66 Hereditary factor VIII deficiency	0.004	0.996	0.000
D56.3 Thalassaemia trait	0.004	0.996	0.000
H34.8 Other retinal vascular occlusions	0.004	0.996	0.000
D72 Other disorders of white blood cells	0.004	0.996	0.000
Z74 Problems related to care-provider dependency	0.000	0.996	0.004
S06.20 Diffuse brain injury (without open intracranial wound)	0.004	0.996	0.000
D67 Hereditary factor IX deficiency	0.004	0.996	0.000
K73.9 Chronic hepatitis, unspecified	0.004	0.996	0.000
D69.2 Other nonthrombocytopenic purpura	0.004	0.996	0.000
U89.9 Agent resistant to unspecified antibiotic	0.004	0.996	0.000
I08.9 Multiple valve disease, unspecified	0.004	0.996	0.000
K61.0 Anal abscess	0.000	0.996	0.004
D70-D77 Other diseases of blood and blood-forming organs	0.004	0.996	0.000
Z74.1 Need for assistance with personal care	0.000	0.996	0.004
I07.9 Tricuspid valve disease, unspecified	0.004	0.996	0.000
I07.8 Other tricuspid valve diseases	0.004	0.996	0.000
I07.2 Tricuspid stenosis with insufficiency	0.004	0.996	0.000
I07.0 Tricuspid stenosis	0.004	0.996	0.000
D69.0 Allergic purpura	0.004	0.996	0.000
M95.0 Acquired deformity of nose	0.004	0.996	0.000
R22.4 Localised swelling, mass and lump, lower limb	0.000	0.996	0.004
D69.8 Other specified haemorrhagic conditions	0.004	0.996	0.000
D69.1 Qualitative platelet defects	0.004	0.996	0.000
D57 Sickle-cell disorders	0.003	0.996	0.000
D55 Anaemia due to enzyme disorders	0.003	0.996	0.000
D56.1 Beta thalassaemia	0.003	0.996	0.000
I09 Other rheumatic heart diseases	0.003	0.996	0.000
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system	0.003	0.996	0.000
D50-D53 Nutritional anaemias	0.003	0.997	0.000
D72.1 Eosinophilia	0.003	0.997	0.000
D56.9 Thalassaemia, unspecified	0.003	0.997	0.000
D56.8 Other thalassaemias	0.003	0.997	0.000
D56.4 Hereditary persistence of foetal haemoglobin [HPFH]	0.003	0.997	0.000
D56.2 Delta-beta thalassaemia	0.003	0.997	0.000
D56.0 Alpha thalassaemia	0.003	0.997	0.000
D59 Acquired haemolytic anaemia	0.003	0.997	0.000
U84 Resistance to other antimicrobial drugs	0.003	0.997	0.000
U83 Resistance to other antibiotics	0.003	0.997	0.000
U82 Resistance to betalactam antibiotics	0.003	0.997	0.000
U85 Resistance to antineoplastic drugs	0.003	0.997	0.000
I06 Rheumatic aortic valve diseases	0.003	0.997	0.000
F10.0 Acute intoxication	0.003	0.997	0.000
Z36.8 Other antenatal screening	0.000	0.997	0.003
F10 Mental and behavioural disorders due to use of alcohol	0.003	0.997	0.000
K61 Abscess of anal and rectal regions	0.000	0.997	0.003
D69.9 Haemorrhagic condition, unspecified	0.003	0.997	0.000
Z94.0 Kidney transplant status	0.003	0.997	0.000
D52 Folate deficiency anaemia	0.003	0.997	0.000
D52.9 Folate deficiency anaemia, unspecified	0.003	0.997	0.000
D72.9 Disorder of white blood cells, unspecified	0.003	0.997	0.000
D72.0 Genetic anomalies of leukocytes	0.003	0.997	0.000
D76.3 Other histiocytosis syndromes	0.003	0.997	0.000
Z74.9 Problem related to care-provider dependency, unspecified	0.000	0.997	0.003
Z74.3 Need for continuous supervision	0.000	0.997	0.003
D69.4 Other primary thrombocytopenia	0.003	0.997	0.000
D39.1 Ovary	0.003	0.997	0.000
C69.3 Choroid	0.003	0.997	0.000
F10.2 Dependence syndrome	0.003	0.997	0.000
I05 Rheumatic mitral valve diseases	0.003	0.997	0.000
I08.2 Disorders of both aortic and tricuspid valves	0.003	0.997	0.000
N70.9 Salpingitis and oophoritis, unspecified	0.003	0.997	0.000
Z74.8 Other problems related to care-provider dependency	0.000	0.997	0.003
D74 Methaemoglobinaemia	0.003	0.997	0.000
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere	0.003	0.997	0.000
D71 Functional disorders of polymorphonuclear neutrophils	0.003	0.997	0.000
M82.11 Osteoporosis in endocrine disorders (Shoulder region)	0.003	0.997	0.000
I08.1 Disorders of both mitral and tricuspid valves	0.003	0.997	0.000
I09.9 Rheumatic heart disease, unspecified	0.003	0.997	0.000
K76.9 Liver disease, unspecified	0.003	0.997	0.000
K44.9 Diaphragmatic hernia without obstruction or gangrene	0.003	0.997	0.000
D68 Other coagulation defects	0.003	0.997	0.000
D55.9 Anaemia due to enzyme disorder, unspecified	0.003	0.997	0.000
D55.8 Other anaemias due to enzyme disorders	0.003	0.997	0.000
D55.3 Anaemia due to disorders of nucleotide metabolism	0.003	0.997	0.000
D55.2 Anaemia due to disorders of glycolytic enzymes	0.003	0.997	0.000
D55.1 Anaemia due to other disorders of glutathione metabolism	0.003	0.997	0.000
D55.0 Anaemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency	0.003	0.997	0.000
D57.8 Other sickle-cell disorders	0.003	0.997	0.000
D57.3 Sickle-cell trait	0.003	0.997	0.000
D57.2 Double heterozygous sickling disorders	0.003	0.997	0.000
D57.1 Sickle-cell anaemia without crisis	0.003	0.997	0.000
D57.0 Sickle-cell anaemia with crisis	0.003	0.997	0.000
D58 Other hereditary haemolytic anaemias	0.002	0.997	0.000
H34 Retinal vascular occlusions	0.003	0.997	0.000
D69.5 Secondary thrombocytopenia	0.003	0.997	0.000
I09.8 Other specified rheumatic heart diseases	0.003	0.997	0.000
I09.2 Chronic rheumatic pericarditis	0.003	0.997	0.000
I09.1 Rheumatic diseases of endocardium, valve unspecified	0.003	0.997	0.000
I09.0 Rheumatic myocarditis	0.003	0.997	0.000
D73 Diseases of spleen	0.003	0.997	0.000
D59.1 Other autoimmune haemolytic anaemias	0.003	0.997	0.000
I08.8 Other multiple valve diseases	0.003	0.997	0.000
Z74.2 Need for assistance at home and no other household member able to render care	0.000	0.997	0.003
D76.2 Haemophagocytic syndrome, infection-associated	0.003	0.997	0.000
D76.1 Haemophagocytic lymphohistiocytosis	0.003	0.997	0.000
D76.0 Langerhans' cell histiocytosis, not elsewhere classified	0.003	0.997	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.000	0.997	0.003
H34.2 Other retinal artery occlusions	0.003	0.997	0.000
I06.0 Rheumatic aortic stenosis	0.003	0.997	0.000
D59.8 Other acquired haemolytic anaemias	0.002	0.997	0.000
D59.6 Haemoglobinuria due to haemolysis from other external causes	0.002	0.997	0.000
D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]	0.002	0.997	0.000
D59.4 Other nonautoimmune haemolytic anaemias	0.002	0.997	0.000
D59.3 Haemolytic-uraemic syndrome	0.002	0.997	0.000
D59.2 Drug-induced nonautoimmune haemolytic anaemia	0.002	0.997	0.000
D59.0 Drug-induced autoimmune haemolytic anaemia	0.002	0.997	0.000
K61.4 Intrasphincteric abscess	0.000	0.997	0.003
U82.9 Resistance to betalactam antibiotics, unspecified	0.003	0.997	0.000
U82.8 Resistance to other betalactam antibiotics	0.003	0.997	0.000
U82.2 Extended spectrum betalactamase (ESBL) resistance	0.003	0.997	0.000
U82.1 Resistance to methicillin	0.003	0.997	0.000
U82.0 Resistance to penicillin	0.003	0.997	0.000
U83.9 Resistance to unspecified antibiotic	0.003	0.997	0.000
U83.8 Resistance to other single specified antibiotic	0.003	0.997	0.000
U83.7 Resistance to multiple antibiotics	0.003	0.997	0.000
U83.2 Resistance to quinolones	0.003	0.997	0.000
U83.1 Resistance to other vancomycin related antibiotics	0.003	0.997	0.000
U83.0 Resistance to vancomycin	0.003	0.997	0.000
U84.9 Resistance to unspecified antimicrobial drugs	0.003	0.997	0.000
U84.8 Resistance to other specified antimicrobial drug	0.003	0.997	0.000
U84.7 Resistance to multiple antimicrobial drugs	0.003	0.997	0.000
U84.3 Resistance to tuberculostatic drug(s)	0.003	0.997	0.000
U84.2 Resistance to antiviral drug(s)	0.003	0.997	0.000
U84.1 Resistance to antifungal drug(s)	0.003	0.997	0.000
U84.0 Resistance to antiparasitic drug(s)	0.003	0.997	0.000
I06.9 Rheumatic aortic valve disease, unspecified	0.003	0.997	0.000
I06.8 Other rheumatic aortic valve diseases	0.003	0.997	0.000
I06.2 Rheumatic aortic stenosis with insufficiency	0.003	0.997	0.000
I06.1 Rheumatic aortic insufficiency	0.003	0.997	0.000
F10.8 Other mental and behavioural disorders	0.003	0.997	0.000
F10.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
K61.2 Anorectal abscess	0.000	0.997	0.003
D52.8 Other folate deficiency anaemias	0.003	0.997	0.000
D52.1 Drug-induced folate deficiency anaemia	0.003	0.997	0.000
D52.0 Dietary folate deficiency anaemia	0.003	0.997	0.000
F10.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.003	0.997	0.000
D68.8 Other specified coagulation defects	0.003	0.997	0.000
C69 Malignant neoplasm of eye and adnexa	0.003	0.997	0.000
C71.9 Brain, unspecified	0.003	0.997	0.000
T40.4 Other synthetic narcotics	0.003	0.997	0.000
D73.4 Cyst of spleen	0.002	0.997	0.000
F10.5 Psychotic disorder	0.002	0.997	0.000
H34.1 Central retinal artery occlusion	0.003	0.997	0.000
I05.0 Mitral stenosis	0.002	0.997	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.000	0.997	0.003
K61.1 Rectal abscess	0.000	0.997	0.002
I05.8 Other mitral valve diseases	0.002	0.997	0.000
D73.3 Abscess of spleen	0.002	0.997	0.000
I05.9 Mitral valve disease, unspecified	0.002	0.997	0.000
D68.5 Primary Thrombophilia	0.002	0.998	0.000
D74.9 Methaemoglobinaemia, unspecified	0.002	0.998	0.000
D74.8 Other methaemoglobinaemias	0.002	0.998	0.000
D74.0 Congenital methaemoglobinaemia	0.002	0.998	0.000
I05.2 Mitral stenosis with insufficiency	0.002	0.998	0.000
D53 Other nutritional anaemias	0.002	0.998	0.000
D73.5 Infarction of spleen	0.002	0.998	0.000
C38 Malignant neoplasm of heart, mediastinum and pleura	0.002	0.998	0.000
D68.4 Acquired coagulation factor deficiency	0.002	0.998	0.000
D68.1 Hereditary factor XI deficiency	0.002	0.998	0.000
L29.2 Pruritus vulvae	0.002	0.998	0.000
D58.2 Other haemoglobinopathies	0.002	0.998	0.000
D59.9 Acquired haemolytic anaemia, unspecified	0.002	0.998	0.000
D68.6 Other Thrombophilia	0.002	0.998	0.000
L29.8 Other pruritus	0.002	0.998	0.000
D58.8 Other specified hereditary haemolytic anaemias	0.002	0.998	0.000
D58.1 Hereditary elliptocytosis	0.002	0.998	0.000
C69.9 Eye, unspecified	0.002	0.998	0.000
D73.9 Disease of spleen, unspecified	0.002	0.998	0.000
D73.2 Chronic congestive splenomegaly	0.002	0.998	0.000
D73.1 Hypersplenism	0.002	0.998	0.000
H34.0 Transient retinal artery occlusion	0.002	0.998	0.000
M07.3 Other psoriatic arthropathies	0.000	0.998	0.002
Z89.4 Acquired absence of foot and ankle	0.000	0.998	0.002
C69.0 Conjunctiva	0.002	0.998	0.000
C38.4 Pleura	0.002	0.998	0.000
H02.1 Ectropion of eyelid	0.000	0.998	0.002
L29 Pruritus	0.002	0.998	0.000
D73.8 Other diseases of spleen	0.002	0.998	0.000
E04.1 Non-toxic single thyroid nodule	0.002	0.998	0.000
F10.6 Amnesic syndrome	0.002	0.998	0.000
H34.9 Retinal vascular occlusion, unspecified	0.002	0.998	0.000
J39.8 Other specified diseases of upper respiratory tract	0.000	0.998	0.002
N70.1 Chronic salpingitis and oophoritis	0.002	0.998	0.000
Z89.5 Acquired absence of leg at or below knee	0.000	0.998	0.002
H61.0 Perichondritis of external ear	0.000	0.998	0.002
D50 Iron deficiency anaemia	0.002	0.998	0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.002	0.998	0.000
D50.8 Other iron deficiency anaemias	0.002	0.998	0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.002	0.998	0.000
C31 Malignant neoplasm of accessory sinuses	0.002	0.998	0.000
C33 Malignant neoplasm of trachea	0.002	0.998	0.000
S62.80 Fracture of other and unspecified parts of wrist and hand (closed)	0.002	0.998	0.000
C69.8 Overlapping lesion of eye and adnexa	0.002	0.998	0.000
C69.6 Orbit	0.002	0.998	0.000
C69.5 Lachrymal gland and duct	0.002	0.998	0.000
C69.4 Ciliary body	0.002	0.998	0.000
C69.2 Retina	0.002	0.998	0.000
C69.1 Cornea	0.002	0.998	0.000
F17.2 Dependence syndrome	0.002	0.998	0.000
I05.1 Rheumatic mitral insufficiency	0.002	0.998	0.000
L29.0 Pruritus ani	0.002	0.998	0.000
R23.3 Spontaneous ecchymoses	0.002	0.998	0.000
C37 Malignant neoplasm of thymus	0.002	0.998	0.000
K11.6 Mucocele of salivary gland	0.002	0.998	0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.002	0.998	0.000
L23.1 Allergic contact dermatitis due to adhesives	0.002	0.998	0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.002	0.998	0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.002	0.998	0.000
D68.0 Von Willebrand's disease	0.002	0.998	0.000
F19.2 Dependence syndrome	0.002	0.998	0.000
M95 Other acquired deformities of musculoskeletal system and connective tissue	0.002	0.998	0.000
N70 Salpingitis and oophoritis	0.002	0.998	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.002	0.998	0.000
Z89 Acquired absence of limb	0.000	0.998	0.002
D53.8 Other specified nutritional anaemias	0.002	0.998	0.000
D53.2 Scorbutic anaemia	0.002	0.998	0.000
D53.1 Other megaloblastic anaemias, not elsewhere classified	0.002	0.998	0.000
D53.0 Protein deficiency anaemia	0.002	0.998	0.000
F10.4 Withdrawal state with delirium	0.002	0.998	0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.002	0.998	0.000
C38.3 Mediastinum, part unspecified	0.002	0.998	0.000
C38.2 Posterior mediastinum	0.002	0.998	0.000
C38.1 Anterior mediastinum	0.002	0.998	0.000
C38.0 Heart	0.002	0.998	0.000
F13.2 Dependence syndrome	0.002	0.998	0.000
C71 Malignant neoplasm of brain	0.002	0.998	0.000
D58.0 Hereditary spherocytosis	0.001	0.998	0.001
F11 Mental and behavioural disorders due to use of opioids	0.002	0.998	0.000
F81.9 Developmental disorder of scholastic skills, unspecified	0.000	0.998	0.002
S06.2 Diffuse brain injury	0.002	0.998	0.000
W17.4 Street and highway	0.002	0.998	0.000
D58.9 Hereditary haemolytic anaemia, unspecified	0.001	0.998	0.001
Z89.6 Acquired absence of leg above knee	0.000	0.998	0.002
D60-D64 Aplastic and other anaemias	0.002	0.998	0.000
D69.3 Idiopathic thrombocytopenic purpura	0.002	0.998	0.000
K05.6 Periodontal disease, unspecified	0.002	0.998	0.000
M07.38 Other psoriatic arthropathies (Other)	0.000	0.998	0.002
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.000	0.998	0.002
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.000	0.998	0.002
M07.34 Other psoriatic arthropathies (Hand)	0.000	0.998	0.002
M07.33 Other psoriatic arthropathies (Forearm)	0.000	0.998	0.002
M07.32 Other psoriatic arthropathies (Upper arm)	0.000	0.998	0.002
M07.31 Other psoriatic arthropathies (Shoulder region)	0.000	0.998	0.002
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
K81.9 Cholecystitis, unspecified	0.002	0.998	0.000
L29.3 Anogenital pruritus, unspecified	0.002	0.998	0.000
L29.1 Pruritus scroti	0.002	0.998	0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.002	0.998	0.000
C25.0 Head of pancreas	0.000	0.998	0.002
H61.2 Impacted cerumen	0.000	0.998	0.002
Z89.2 Acquired absence of upper limb above wrist	0.000	0.998	0.002
G93.4 Encephalopathy, unspecified	0.002	0.998	0.000
M82.1 Osteoporosis in endocrine disorders	0.002	0.998	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.000	0.998	0.002
D50.1 Sideropenic dysphagia	0.002	0.998	0.000
D68.9 Coagulation defect, unspecified	0.002	0.998	0.000
Y45.1 Salicylates	0.000	0.998	0.002
F18 Mental and behavioural disorders due to use of volatile solvents	0.002	0.998	0.000
F16 Mental and behavioural disorders due to use of hallucinogens	0.002	0.998	0.000
F14 Mental and behavioural disorders due to use of cocaine	0.002	0.998	0.000
C31.9 Accessory sinus, unspecified	0.002	0.998	0.000
C31.8 Overlapping lesion of accessory sinuses	0.002	0.998	0.000
C31.3 Sphenoidal sinus	0.002	0.998	0.000
C31.2 Frontal sinus	0.002	0.998	0.000
C31.1 Ethmoidal sinus	0.002	0.998	0.000
C31.0 Maxillary sinus	0.002	0.998	0.000
C39.9 Ill-defined sites within the respiratory system	0.002	0.998	0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.002	0.998	0.000
C39.0 Upper respiratory tract, part unspecified	0.002	0.998	0.000
D39.7 Other female genital organs	0.002	0.998	0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.002	0.998	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.002	0.998	0.000
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)	0.002	0.998	0.000
D68.2 Hereditary deficiency of other clotting factors	0.002	0.998	0.000
M95.2 Other acquired deformity of head	0.002	0.998	0.000
L29.9 Pruritus, unspecified	0.002	0.998	0.000
F11.1 Harmful use	0.002	0.998	0.000
F19.9 Unspecified mental and behavioural disorder	0.002	0.998	0.000
F19.8 Other mental and behavioural disorders	0.002	0.998	0.000
F19.7 Residual and late-onset psychotic disorder	0.002	0.998	0.000
F19.6 Amnesic syndrome	0.002	0.998	0.000
F19.5 Psychotic disorder	0.002	0.998	0.000
F19.4 Withdrawal state with delirium	0.002	0.998	0.000
F19.3 Withdrawal state	0.002	0.998	0.000
F19.1 Harmful use	0.002	0.998	0.000
F19.0 Acute intoxication	0.002	0.998	0.000
Z89.0 Acquired absence of finger(s) [including thumb], unilateral	0.000	0.998	0.002
G51 Facial nerve disorders	0.000	0.998	0.002
F45.8 Other somatoform disorders	0.002	0.998	0.000
L23 Allergic contact dermatitis	0.002	0.998	0.000
F13.9 Unspecified mental and behavioural disorder	0.002	0.998	0.000
F13.8 Other mental and behavioural disorders	0.002	0.998	0.000
F13.7 Residual and late-onset psychotic disorder	0.002	0.998	0.000
F13.6 Amnesic syndrome	0.002	0.998	0.000
F13.5 Psychotic disorder	0.002	0.998	0.000
F13.4 Withdrawal state with delirium	0.002	0.998	0.000
F13.3 Withdrawal state	0.002	0.998	0.000
F13.1 Harmful use	0.002	0.998	0.000
F13.0 Acute intoxication	0.002	0.998	0.000
M95.9 Acquired deformity of musculoskeletal system, unspecified	0.002	0.998	0.000
M95.8 Other specified acquired deformities of musculoskeletal system	0.002	0.998	0.000
M95.5 Acquired deformity of pelvis	0.002	0.998	0.000
M95.3 Acquired deformity of neck	0.002	0.998	0.000
M95.1 Cauliflower ear	0.002	0.998	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.002	0.998	0.000
C30.1 Middle ear	0.002	0.998	0.000
C71.3 Parietal lobe	0.002	0.998	0.000
F11.3 Withdrawal state	0.002	0.998	0.000
K05.1 Chronic gingivitis	0.002	0.998	0.000
Z89.9 Acquired absence of limb, unspecified	0.000	0.998	0.002
Z89.8 Acquired absence of upper and lower limbs [any level]	0.000	0.998	0.002
Z89.3 Acquired absence of both upper limbs [any level]	0.000	0.998	0.002
Z89.1 Acquired absence of hand and wrist	0.000	0.998	0.002
D61 Other aplastic anaemias	0.002	0.998	0.000
J33 Nasal polyp	0.002	0.998	0.000
M21.07 Valgus deformity, not elsewhere classified (Ankle and foot)	0.002	0.998	0.000
C71.1 Frontal lobe	0.002	0.998	0.000
D39.0 Uterus	0.002	0.998	0.000
J33.1 Polypoid sinus degeneration	0.002	0.998	0.000
L23.9 Allergic contact dermatitis, unspecified cause	0.002	0.998	0.000
C71.7 Brain stem	0.002	0.998	0.000
C71.6 Cerebellum	0.002	0.998	0.000
C71.5 Cerebral ventricle	0.002	0.998	0.000
C71.4 Occipital lobe	0.002	0.998	0.000
D53.9 Nutritional anaemia, unspecified	0.001	0.998	0.000
N70.0 Acute salpingitis and oophoritis	0.002	0.998	0.000
Chapter XXII Codes for special purposes	0.002	0.998	0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.002	0.998	0.000
F11.9 Unspecified mental and behavioural disorder	0.002	0.998	0.000
F11.8 Other mental and behavioural disorders	0.002	0.998	0.000
F11.7 Residual and late-onset psychotic disorder	0.002	0.998	0.000
F11.6 Amnesic syndrome	0.002	0.998	0.000
F11.5 Psychotic disorder	0.002	0.998	0.000
F11.4 Withdrawal state with delirium	0.002	0.998	0.000
F11.0 Acute intoxication	0.002	0.998	0.000
Z89.7 Acquired absence of both lower limbs [any level, except toes alone]	0.000	0.998	0.002
F17 Mental and behavioural disorders due to use of tobacco	0.002	0.998	0.000
S06.21 Diffuse brain injury (with open intracranial wound)	0.002	0.998	0.000
C71.8 Overlapping lesion of brain	0.002	0.998	0.000
M95.4 Acquired deformity of chest and rib	0.002	0.998	0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.002	0.998	0.000
D60 Acquired pure red cell aplasia [erythroblastopenia]	0.002	0.998	0.000
D61.1 Drug-induced aplastic anaemia	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations